Antaros Medical, as part of a collaboration with Sahlgrenska University Hospital and AstraZeneca, will present new follow-up data at this year’s Kidney Week. The abstract ‘Trajectory of kidney function correlates with renal blood flow evaluated by Magnetic Resonance Imaging in diabetic kidney disease’ analyses correlations between baseline and measurements taken two years later, providing longitudinal support for the use of MRI for non-invasive assessment and prediction of diabetic kidney disease progression. It will be presented by Paul Hockings (Senior Director MR Imaging at Antaros Medical and Adjunct Professor at Chalmers University of Technology) on Thursday, November 3rd @ 10:00-12:00.
This data builds on the findings of previous work showing a correlation between mean arterial flow (MAF) in renal arteries, as determined using Magnetic Resonance Imaging (MRI), and measured glomerular filtration rate (mGFR). Glomerular filtration rate is a useful quantitative index of kidney function, and early decline of mGFR has been found to be associated with disease progression. Using MRI to measure MAF over time has the potential to provide a non-invasive way to predict and monitor decline in kidney function in DKD patients.
Find the abstract here.
Abstract title: Trajectory of kidney function correlates with renal blood flow evaluated by Magnetic Resonance Imaging in diabetic kidney disease
Abstract number: TH-PO230
Authors: Hockings P, Makvandi K, Jensen G, Unnerstall T, Leonhardt H, Haraldsson H, Hulthe J, Baid-Agrawal S